Clinical Trial

The Medacta International SMS Post-Marketing Surveillance Study

Name: The Medacta International SMS Post-Marketing Surveillance Study — clinical trial record (NCT02748408)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This is a Post-Marketing Surveillance of SMS femoral stem prosthesis.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2016-04-21; most recent amendment 2025-09-23.

Trial Details

NCT Number	NCT02748408
Lead Sponsor	Medacta International SA
Conditions	Arthrosis, Traumatic Arthritis, Rheumatoid Polyarthritis, Congenital Hip Dysplasia, Avascular Necrosis of the Femoral Head
Enrollment	550 participants
Start Date	2015-07
Primary Completion	2032-07 (estimated)
Study Completion	2032-07 (estimated)
Updated on ClinicalTrials.gov	2025-09-29